Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Reltebon
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Reltebon 10mg modified-release tablets
0407020ADBKABAF
|
Reltebon | Oxycodone hydrochloride | Central Nervous System | 1,191 |
|
Reltebon 20mg modified-release tablets
0407020ADBKACAG
|
Reltebon | Oxycodone hydrochloride | Central Nervous System | 1,047 |
|
Reltebon 5mg modified-release tablets
0407020ADBKAAAK
|
Reltebon | Oxycodone hydrochloride | Central Nervous System | 546 |
|
Reltebon 40mg modified-release tablets
0407020ADBKADAH
|
Reltebon | Oxycodone hydrochloride | Central Nervous System | 499 |
|
Reltebon 15mg modified-release tablets
0407020ADBKAFAS
|
Reltebon | Oxycodone hydrochloride | Central Nervous System | 407 |
|
Reltebon 30mg modified-release tablets
0407020ADBKAGAR
|
Reltebon | Oxycodone hydrochloride | Central Nervous System | 402 |
|
Reltebon 60mg modified-release tablets
0407020ADBKAHAQ
|
Reltebon | Oxycodone hydrochloride | Central Nervous System | 242 |
|
Reltebon 80mg modified-release tablets
0407020ADBKAEAI
|
Reltebon | Oxycodone hydrochloride | Central Nervous System | 199 |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.